South Korea Rolls Out Mandatory Face Scans for New Phone Numbers to Combat Scams
South Korea has begun a trial for mandatory facial recognition when registering new mobile numbers to fight financial scams, raising questions about biometric data privacy and government surveillance.
The South Korean government has launched a trial for a new policy requiring real-time facial recognition to register a mobile phone number, a move aimed at cracking down on financial scams that use illegally registered accounts. According to Yonhap news agency, the trial began on Tuesday, December 23, 2025, with the policy set to be officially implemented in March 2026.
The country's three major mobile carriers—SK Telecom Co., KT Corp., and LG Uplus Inc.—as well as mobile virtual network operators (MVNOs), will be required to enforce the procedure for both in-person and remote sign-ups.
Under the new system, applicants must scan their face using PASS, an identification app developed by the three carriers. The app verifies a match between the live scan and the photo on the applicant's official ID card.
Amid rising concerns about the collection of sensitive biometric information, the government stated that the data will not be stored. Officials claim the process is solely for one-time verification. In addition to this measure, the government also plans to revise laws to compel carriers to notify users of the risks associated with illegally registered phones and to increase their oversight of retailers to prevent fraudulent subscriptions.
This content is AI-generated based on source articles. While we strive for accuracy, errors may occur. We recommend verifying with the original source.
Related Articles
Trump's demand for warships at the Strait of Hormuz has cornered South Korea between alliance loyalty and $68 billion in Middle East exposure. How Seoul decides may define its diplomacy for years.
The US has quietly moved parts of its THAAD missile defense system from South Korea to the Middle East. Analysts see both a short-term gap and a strategic signal — but for whom?
Samsung Biologics and Eli Lilly will co-establish a Lilly Gateway Labs site in Songdo, Incheon by 2027. What does this mean for Korea's biotech ecosystem and global pharma strategy?
South Korea's president pledges to respect North Korea's political system and abandon unification by absorption. But can diplomacy work when Pyongyang calls Seoul its "principal enemy"?
Thoughts
Share your thoughts on this article
Sign in to join the conversation